COX14

COX14 encodes a small single-transmembrane mitochondrial inner-membrane protein that is essential for biogenesis of cytochrome c oxidase (complex IV) but is not itself a structural subunit of the holoenzyme (PMID:7797555, PMID:22243966). Its central function is to couple translation of the mitochondrially encoded COX1 subunit to downstream assembly: COX14 forms an early assembly intermediate nucleated by newly synthesized COX1, and in yeast this complex sequesters the translational activator Mss51 into its latent, translation-resting state, thereby imposing a negative feedback loop that downregulates COX1 synthesis when assembly stalls (PMID:15306853, PMID:19710419, PMID:20876281). Mss51 sequestration requires the C-terminal residues of COX1 and the cooperating factors Coa3/COA3 and Coa1, with which COX14 acts interdependently — COX14 and COA3 are mutually required for each other's stability and reside together in the COX1-containing early intermediate (PMID:20876281, PMID:20807763, PMID:25604084). This assembly intermediate is handed forward through additional factors including Shy1 (SURF1), Cox25, and CMC1 before incorporation of later COX subunits, and at the ribosome level COX14 engages COX1-translating mitoribosomes to enforce a primed translational state when assembly is blocked (PMID:17882259, PMID:21068384, PMID:27693358, PMID:28082314). In humans, the COX14 ortholog C12orf62 performs the analogous coupling role, and its loss causes a specific defect in COX1 synthesis with complex IV deficiency (PMID:22243966, PMID:25604084); a missense mutation causes fatal neonatal lactic acidosis (PMID:22243966). In a corresponding mouse model, COX14 dysfunction triggers excess reactive oxygen species, release of mitochondrial RNA to the cytosol, and RIG-I–mediated inflammation, linking defective complex IV assembly to innate immune activation (PMID:39134548).

1. 1995 High

   Established that COX14 is required for complex IV assembly without being a subunit, distinguishing it as a dedicated assembly factor rather than a structural component.

   Evidence Complementation cloning, Western analysis, and native complex analysis in yeast showing loss of COX activity despite normal Cox1/Cox2/Cox3 synthesis

   PMID:7797555

   Open questions at the time

   • Molecular partners and the step of assembly affected were undefined
   • Mechanism of post-translational action unknown
2. 2004 High

   Identified COX14 as the factor that physically links the translational activator Mss51 to newly made Cox1, defining a negative feedback loop coupling COX1 synthesis to assembly.

   Evidence Reciprocal Co-IP, pulse-labeling of mitochondrial translation, and epistasis with mss51 suppressors in yeast

   PMID:15306853

   Open questions at the time

   • Whether additional factors are needed to form the latent Mss51 state was unresolved
   • Structural basis of the COX14-Mss51-Cox1 interaction unknown
3. 2007 High

   Connected the COX14-Mss51 translational module to the downstream assembly pathway via Shy1/SURF1 and to supercomplex formation.

   Evidence Co-IP and blue-native PAGE identifying COX14-containing intermediates bound to Shy1 and the bc1 complex

   PMID:17882259

   Open questions at the time

   • Order of handoff between intermediates not fully defined
4. 2009 High

   Demonstrated that COX14 is required for Mss51 sequestration and that this interaction depends on active Cox1 synthesis, establishing Cox1 as the nucleating subunit of the early intermediate.

   Evidence Co-IP, pulse-labeling, and reporter assays in cox14 mutant yeast

   PMID:19710419

   Open questions at the time

   • Whether other factors stabilize the intermediate was not yet defined
5. 2010 High

   Resolved the multi-factor composition controlling Mss51 state, showing Coa3, Cox14, and Coa1 together drive the latent (translation-resting) form, and identified Cox25 as a continuing partner after Mss51 release.

   Evidence Co-IP, pulse-labeling, sucrose gradient sedimentation, and yeast genetics across multiple studies

   PMID:20876281 PMID:21068384

   Open questions at the time

   • Stoichiometry and structural arrangement of the intermediate unresolved
6. 2010 High

   Mapped the Cox1 C-terminal residues as the structural determinant required for Mss51 sequestration via COX14, providing a molecular handle for the feedback control.

   Evidence Mitochondrial DNA mutagenesis with Co-IP and pulse-labeling in yeast

   PMID:20807763

   Open questions at the time

   • Direct contact between Cox1 C-terminus and COX14 not structurally demonstrated
7. 2012 High

   Extended the model to humans, identifying C12orf62/COX14 as the ortholog coupling COX1 synthesis to assembly and linking its mutation to fatal mitochondrial disease.

   Evidence Patient genetics, retroviral complementation rescue, siRNA knockdown, Co-IP, BN-PAGE, and pulse-labeling; orthology prediction validated by localization and co-purification

   PMID:22243966 PMID:22356826

   Open questions at the time

   • Human-specific partners beyond COX subunits not fully enumerated
   • Whether human COX14 regulates an Mss51-equivalent activator was unaddressed
8. 2015 High

   Established the mutual stability dependence of COX14 and COA3 in human cells, defining them as an obligate module within the early COX1 intermediate.

   Evidence Immunoblot of patient fibroblasts, BN-PAGE, retroviral complementation, pulse-labeling

   PMID:25604084

   Open questions at the time

   • Biochemical basis of the co-stabilization unknown
9. 2016 High

   Showed that COX14 acts at the level of translating mitoribosomes, engaging COX1-synthesizing ribosome nascent chain complexes to enforce a primed translational state under assembly stress.

   Evidence Ribosome nascent chain complex isolation, mass spectrometry, sucrose gradient sedimentation, BN-PAGE in human cells

   PMID:27693358

   Open questions at the time

   • Precise contacts between COX14 and the mitoribosome unresolved
10. 2017 High

    Dissected division of labor within the early intermediate, distinguishing COX14/COA3 (proposed translational control) from CMC1 (regulation of COX1 turnover) and confirming the Cox1 C-terminus requirement, refining the composition and function of the COX1 assembly hub.

    Evidence CMC1 knockout cells, mitochondrial COX1 mutagenesis, Co-IP, BN-PAGE, pulse-labeling; yeast genetics with MrpL35

    PMID:28082314 PMID:28490636 PMID:28931599

    Open questions at the time

    • Mechanistic coupling between the mitoribosome and the intermediate only partly defined
    • MrpL35 step relies on inferred COX14 involvement
11. 2024 High

    Connected COX14 loss to a downstream pathophysiological cascade in vivo, showing impaired COX1 translation drives ROS, mitochondrial RNA release, and RIG-I–mediated inflammation.

    Evidence COX14 M19I knockin mouse with pulse-labeling, ROS measurement, cytosolic RNA detection, and pathway analysis

    PMID:39134548

    Open questions at the time

    • Tissue specificity of the inflammatory response not fully explained
    • Direct route from ROS to mtRNA release not mechanistically resolved

• How the human COX14 module senses assembly status and feeds back on COX1 translation at structural resolution, and whether a human Mss51-equivalent activator exists, remains unresolved.
• No atomic structure of the COX1-COX14-COA3 intermediate
• Human translational activator analogous to yeast Mss51 not identified